Sympathetic activation, microcirculation, haemostasis and inflammation in diabetic and non-diabetic kidney disease: disease modification by vitamin D receptor activation.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Paricalcitol (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Aug 2011 New trial record